Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (981-990 of 1,023) with videos related to

Pageof 103
Sort By:
Lancet (London, England)|September 7, 2010
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trialShamir R Mehta, Jean-Francois Tanguay, John W Eikelboom, et al.
JAMA Network Open|February 17, 2022
Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular DiseaseAdam J Nelson, Emily C O'Brien, Lisa A Kaltenbach, et al.
The New England Journal of Medicine|June 16, 2023
Cardiovascular Safety of Testosterone-Replacement TherapyA Michael Lincoff, Shalender Bhasin, Panagiotis Flevaris, et al.
European Journal of Heart Failure|April 13, 2026
Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiAMaria Hee Jung Park Frausing, William F McIntyre, Jeff S Healey, et al.
American Heart Journal|October 24, 2022
Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and designAdam J Nelson, Neha J Pagidipati, Michelle D Kelsey, et al.
American Heart Journal|July 31, 2024
RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study rationale and designKonstantin A Krychtiuk, Monique A Starks, Hussein R Al-Khalidi, et al.
American Heart Journal|November 15, 2019
Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trialsJ Matthew Brennan, Lisa Wruck, Michael J Pencina, et al.
The Canadian Journal of Cardiology|April 7, 2023
Neuroprognostication in the Post Cardiac Arrest Patient: A Canadian Cardiovascular Society Position StatementChristopher B Fordyce, Andreas H Kramer, Craig Ainsworth, et al.
American Heart Journal|June 17, 2018
Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trialOtavio Berwanger, Jose C Nicolau, Antonio C Carvalho, et al.
Journal of Thrombosis and Thrombolysis|March 16, 2013
Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, BrazilRenato D Lopes, Richard C Becker, L Kristin Newby, et al.
Pageof 103

Showing results (981-990 of 1,023) with videos related to

Sort By:
Pageof 103
Lancet (London, England)|September 7, 2010
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trialShamir R Mehta, Jean-Francois Tanguay, John W Eikelboom, et al.
JAMA Network Open|February 17, 2022
Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular DiseaseAdam J Nelson, Emily C O'Brien, Lisa A Kaltenbach, et al.
The New England Journal of Medicine|June 16, 2023
Cardiovascular Safety of Testosterone-Replacement TherapyA Michael Lincoff, Shalender Bhasin, Panagiotis Flevaris, et al.
European Journal of Heart Failure|April 13, 2026
Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiAMaria Hee Jung Park Frausing, William F McIntyre, Jeff S Healey, et al.
American Heart Journal|October 24, 2022
Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and designAdam J Nelson, Neha J Pagidipati, Michelle D Kelsey, et al.
American Heart Journal|July 31, 2024
RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study rationale and designKonstantin A Krychtiuk, Monique A Starks, Hussein R Al-Khalidi, et al.
American Heart Journal|November 15, 2019
Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trialsJ Matthew Brennan, Lisa Wruck, Michael J Pencina, et al.
The Canadian Journal of Cardiology|April 7, 2023
Neuroprognostication in the Post Cardiac Arrest Patient: A Canadian Cardiovascular Society Position StatementChristopher B Fordyce, Andreas H Kramer, Craig Ainsworth, et al.
American Heart Journal|June 17, 2018
Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trialOtavio Berwanger, Jose C Nicolau, Antonio C Carvalho, et al.
Journal of Thrombosis and Thrombolysis|March 16, 2013
Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, BrazilRenato D Lopes, Richard C Becker, L Kristin Newby, et al.
Pageof 103